Go Deep
Epigral Limited
Epigral Limited Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 24,852 | 15.0 | 1.83 | 0.26 | 940.00 |
Epigral Limited Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 7,053,600,000.0 | 7,361,600,000.0 | 5,971,200,000.0 | 5,873,600,000.0 |
| Net Profit | 997,400,000.0 | 809,500,000.0 | 391,100,000.0 | 512,200,000.0 |
| EPS | 23.0 | 18.8 | 9.1 | 11.9 |
Epigral Limited Revenue & Profit: Last 5 Years
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Revenue | 24,954,800,000.0 | 25,144,000,000.0 | 18,938,300,000.0 | 21,694,416,000.0 | — |
| Net Profit | 3,319,700,000.0 | 3,576,900,000.0 | 1,958,700,000.0 | 3,532,906,000.0 | — |
| EPS | 77.0 | 84.7 | 47.1 | 85.0 | — |
Epigral Limited Balance Sheet
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Total Assets | 35,053,000,000.0 | 31,524,400,000.0 | 27,943,400,000.0 | 24,322,353,000.0 | — |
| Total Liabilities | 12,838,700,000.0 | 12,479,100,000.0 | 15,402,400,000.0 | 13,631,351,000.0 | — |
| Total Equity | 22,214,300,000.0 | 19,045,300,000.0 | 12,541,000,000.0 | 10,691,002,000.0 | — |
Owes vs Owns
Epigral Limited owed ₹0.37 for every ₹1 it owned in Mar 2026, down from ₹0.56 in Mar 2023.
| Period | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Owes vs Owns | 0.37× | 0.40× | 0.55× | 0.56× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Epigral Limited Assets & Liabilities Breakdown (₹ Cr)
What it owns — Mar 2026
Receivables 11.9%Inventory 9.9%Fixed assets (tangible) 73.2%Long-term investments 0.6%Other assets 3.7%
How it's funded — Mar 2026
Short-term debt 6.5%Long-term debt 9.5%Payables 7.4%Other liabilities 13.2%Shareholders' equity 63.4%
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 6.4 | 96.5 | 3.2 | 14.2 |
| Receivables | 416.5 | 232.3 | 178.8 | 166.3 |
| Inventory | 348.6 | 388.0 | 263.0 | 211.8 |
| Fixed assets (tangible) | 2,567.0 | 2,311.3 | 2,234.6 | 1,952.4 |
| Intangible assets | 15.5 | 18.7 | 22.0 | 25.2 |
| Long-term investments | 20.6 | 21.5 | 20.6 | 20.5 |
| Other assets | 130.7 | 84.1 | 72.3 | 41.7 |
| Liabilities & equity | ||||
| Short-term debt | 229.3 | 135.6 | 415.6 | 331.5 |
| Long-term debt | 333.7 | 449.0 | 492.0 | 434.6 |
| Payables | 259.7 | 185.7 | 183.9 | 110.2 |
| Other liabilities | 461.2 | 477.6 | 448.6 | 486.8 |
| Shareholders' equity | 2,221.4 | 1,904.5 | 1,254.1 | 1,069.1 |
| Net tangible assets | 2,205.9 | 1,885.8 | 1,232.1 | 1,043.9 |
Epigral Limited Cash Flow
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Operating Activities | 4,355,300,000.0 | 4,405,600,000.0 | 3,976,400,000.0 | 6,261,617,000.0 | — |
| Investing Activities | -3,546,700,000.0 | -2,615,600,000.0 | -4,011,000,000.0 | -4,372,198,000.0 | — |
| Financing Activities | -944,800,000.0 | -1,635,400,000.0 | -76,000,000.0 | -1,997,873,000.0 | — |